Does beta-blocker therapy reduce the risk of aborted cardiac arrest or sudden cardiac death in children with congenital long-QT syndrome?
In children with congenital long-QT syndrome, boys have a higher rate of fatal or near-fatal events than girls, with QTc > 500 ms and prior syncope as key risk factors, while beta-blocker therapy significantly reduces the risk of life-threatening events.
BACKGROUND: The congenital long-QT syndrome (LQTS) is an important cause of sudden cardiac death in children without structural heart disease. However, specific risk factors for life-threatening cardiac events in children with this genetic disorder have not been identified. METHODS AND RESULTS: Cox proportional-hazards regression modeling was used to identify risk factors for aborted cardiac arrest or sudden cardiac death in 3015 LQTS children from the International LQTS Registry who were followed up from 1 through 12 years of age. The cumulative probability of the combined end point was significantly higher in boys (5%) than in girls (1%; P 500 ms (hazard ratio HR; 2.72; 95% confidence interval CI, 1.50 to 4.92; P=0.001) and prior syncope (recent syncope or = 2 years: HR, 2.67; 95% CI, 1.22 to 5.85; P=0.01) in boys, whereas prior syncope was the only significant risk factor among girls (recent syncope: HR, 27.82; 95% CI, 9.72 to 79.60; P 500 ms and a history of prior syncope identify risk in boys, whereas prior syncope is the only significant risk factor among girls. Beta-blocker therapy is associated with a significant reduction in the risk of life-threatening cardiac events during childhood.
Goldenberg et al. (Tue,) studied this question.